Displaying drugs 13176 - 13200 of 14915 in total
Sulanemadlin
Investigational
Omburtamab
CD276 (B7-H3) is a B7/CD28 immunoglobulin superfamily member frequently expressed among solid human tumours.[A242487, A242492] Omburtamab, formerly the murine anti-B7-H3 antibody 8H9, and its humanized forms are currently under clinical development for use in various cancers. Omburtamab is under investigation in clinical trial NCT03275402 (131i-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous...
Investigational
Matched Description: … [A242487, A242492] Omburtamab, formerly the murine anti-B7-H3 antibody 8H9, and its humanized forms are …
APL-9
APL-9 is an investigational drug intended to centrally control the complement cascade at C3, potentially treating various diseases caused by excessive or uncontrolled complement activation. It shares the same mechanism of action as Apellis’ lead compound, pegcetacoplan (APL-2), but with a lower molecular weight and shorter half-life. APL-9 is designed...
Investigational
Matched Description: … mechanism of action as Apellis’ lead compound, pegcetacoplan (APL-2), but with a lower molecular weight and …
Brodimoprim-4,6-Dicarboxylate
Brodimoprim-4,6-dicarboxylate is a solid. This compound belongs to the anisoles. These are organic compounds contaiing a methoxybenzene or a derivative thereof. This medication is known to target the protein dihydrofolate reductase.
Experimental
7-Hydroxystaurosporine
Experimental
Investigational
Zk-806450
Experimental
K-252a
Experimental
2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine
Experimental
D-galactohydroximo-1,5-lactam
Experimental
CRA_10433
Experimental
2-Pyridinethiol
Experimental
SU9516
Experimental
6-bromoindirubin-3'-oxime
Experimental
Bisindolylmaleimide I
Experimental
CRA_9076
Experimental
(3s)-2,3,4,5-Tetrahydropyridin-3-Amine
Experimental
CRA_9678
Experimental
Indibulin
Investigational
Displaying drugs 13176 - 13200 of 14915 in total